Key result
Higher perivascular adipose tissue attenuation links to MACCE and ~116% higher risk of AAA-related events after EVAR.
Why the study?
The prognostic value of perivascular adipose tissue attenuation on computed tomography angiography in patients undergoing EVAR for AAA remains unclear.
Does higher perivascular adipose tissue (PVAT) attenuation on preprocedural CT angiography predict MACCE and AAA-related adverse events in patients undergoing EVAR for unruptured infrarenal AAA?
Cohort
Does higher perivascular adipose tissue (PVAT) attenuation on preprocedural CT angiography predict MACCE and AAA-related adverse events in patients undergoing EVAR for unruptured infrarenal AAA?
p-value: p=<0.001
Higher PVAT attenuation on preprocedural CT angiography provides incremental prognostic value for predicting MACCE and AAA-related adverse events in patients undergoing EVAR.
May warrant closer post-EVAR surveillance with elevated PVAT; leaves open routine prognostic use pending prospective validation.
BACKGROUND: Perivascular adipose tissue (PVAT) attenuation on computed tomography angiography reflects vascular inflammation. However, its prognostic value in patients undergoing endovascular aortic repair (EVAR) for abdominal aortic aneurysm (AAA) remains unclear. METHODS: We retrospectively studied consecutive patients who underwent EVAR for unruptured infrarenal AAA with preprocedural computed tomography angiography. PVAT attenuation and aortic characteristics were assessed using computed tomography angiography. The primary outcome was major adverse cardiac or cerebrovascular events (MACCE), a composite of all-cause death, myocardial infarction, stroke, and any vessel treatment. RESULTS: <0.001) was associated with MACCE after EVAR. Furthermore, higher PVAT attenuation was associated with AAA-related adverse events: a composite of AAA-related death, reintervention for AAA, embolization for endoleak, and AAA enlargement (per 10 HU; unadjusted hazard ratio, 2.16 [95% CI, 1.59-2.94]). Adding PVAT attenuation to post-EVAR prognostic factors and computed tomography angiography findings improved the predictive and reclassification abilities for MACCE after EVAR. CONCLUSIONS: In patients undergoing EVAR, higher PVAT attenuation was associated with both MACCE and AAA-related adverse events. PVAT attenuation may provide incremental prognostic value for identifying patients at higher risk of unfavorable outcomes following EVAR.
No takes yet. Share an insight, caveat, or question.
Matsuhama et al. (2026) conducted a cohort in Abdominal aortic aneurysm undergoing endovascular aortic repair. Perivascular adipose tissue (PVAT) attenuation was evaluated on Major adverse cardiac or cerebrovascular events (MACCE), a composite of all-cause death, myocardial infarction, stroke, and any vessel treatment (p=<0.001). Higher perivascular adipose tissue attenuation was associated with increased risk of MACCE (P<0.001) and AAA-related adverse events (HR 2.16; 95% CI 1.59-2.94) after EVAR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: